A 2012 critique of cost-effectiveness study for TCM uncovered that reports experienced small amounts of evidence, without any beneficial results.[fifty one] Pharmaceutical exploration about the prospective for building new medication from classic therapies has couple effective outcomes.[2] Proponents propose that investigate has so far missed criti